Clinical Trial Update: Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial not yet recruiting evaluating low-dose radiotherapy in patients with advanced esophageal squamous cell carcinoma resistant to first-line chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Esophageal Adenocarcinoma, Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING